Clinical trial NCT06115200: Norwegian Adult Mental Health Registry
Official title: Norwegian Adult Mental Health Registry
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Depression
Schizophrenia
Bipolar Disorder
Eating Disorders
Anxiety Disorders
Ptsd
Personality Disorders
Adhd
Keywords: database
epidemiology
mental health register
Lead sponsor: Helse Stavanger HF
Sponsor class: OTHER_GOV
First posted: 2023-11-02
Enrollment: 150000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Residents in Norway aged 18 years or older and granted right to treatment in mental specialized in- and out-patient settings (approximately 150.000 participants)

Brief summary: "The Norwegian Adult Mental Health Registry" (NAMHR) is a medical quality register collecting and systematizing data on patients and their treatment in specialist mental health care for adults in Norway. The main purpose is to create a documentation basis for quality assurance, evaluation, and improvement of assessment and treatment for patients who are offered treatment for mental disorders in the specialist health service. The register uses automatic data capture from various existing data sources. New patients are automatically included, but given the opportunity for reservations from the register without affecting their services and treatment.


Eligibility criteria: Inclusion Criteria:

* Residents in Norway aged 18 years or older assessed and granted right to treatment in specialized mental in- and out-patient settings

Exclusion Criteria:

* Persons who have reserved themselves against participation
* Persons already included in more specialized register for mental disorder and/or treatment

Primary outcomes:
measure: Patient Reported Outcome Measures (PROMs)
timeFrame: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months
measure: Patient Reported Outcome Measures (PROMs)
timeFrame: Discharge defined as: date of discharge from any cause, assessed up to 60 months
measure: Patient Reported Outcome Measures (PROMs)
timeFrame: Six months after discharge
measure: Drug name and dosage from electronic medication management solutions
timeFrame: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months
measure: Drug name and dosage from electronic medication management solutions
timeFrame: Discharge defined as: date of discharge from any cause, assessed up to 60 months
measure: Drug name and dosage from electronic medication management solutions
timeFrame: Six months after discharge from any cause, assessed up to 12 months
measure: Rate of overweight defined as BMI > 25 (body mass index)
timeFrame: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months
measure: Rate of overweight defined as BMI > 25 (body mass index)
timeFrame: Discharge defined as: date of discharge from any cause, assessed up to 60 months
measure: Level of glycated haemoglobin (HbA1c)
timeFrame: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months
measure: Level of glycated haemoglobin (HbA1c)
timeFrame: Discharge defined as: date of discharge from any cause, assessed up to 60 months
measure: Level of blood pressure, both systolic and diastolic levels
timeFrame: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months
measure: Level of blood pressure, both systolic and diastolic levels
timeFrame: Discharge defined as: date of discharge from any cause, assessed up to 60 months
measure: Bloodlevels of total cholesterol, LDL, HDL and Triglycerides
timeFrame: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months
measure: Bloodlevels of total cholesterol, LDL, HDL and Triglycerides
timeFrame: Discharge defined as: date of discharge from any cause, assessed up to 60 months
measure: Frequency of ICD-10 or ICD-11 diagnosis F00-F99
timeFrame: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months
measure: Frequency of ICD-10 or ICD-11 diagnosis F00-F99
timeFrame: Discharge defined as: date of discharge from any cause, assessed up to 60 months
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Stavanger University hospital, Stavanger, Norway
name: Inge Joa, PhD
role: PRINCIPAL_INVESTIGATOR
References: